Cargando…

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very heterogeneous with varying and mostly poor prognosis. It is also called “locoregionally or locally advanced disease”. Due to its heterogeneity a general schematic management approach is not appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huber, Rudolf M., De Ruysscher, Dirk, Hoffmann, Hans, Reu, Simone, Tufman, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488854/ https://www.ncbi.nlm.nih.gov/pubmed/31285288 http://dx.doi.org/10.1183/16000617.0024-2019

Ejemplares similares

New developments in locally advanced nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2021)

A persistent pneumothorax? 5-year follow-up after diagnosis of Swyer–James–MacLeod syndrome
por: Tufman, Amanda, et al.
Publicado: (2016)

Can MicroRNAs Improve the Management of Lung Cancer Patients? A Clinician's Perspective
por: Tufman, Amanda, et al.
Publicado: (2013)

Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
por: Tufman, Amanda, et al.
Publicado: (2017)

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
por: Putora, Paul Martin, et al.
Publicado: (2020)

Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2021)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014)

Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation
por: Li, Jing, et al.
Publicado: (2020)

Endoplasmic reticulum Ca(2+)-homeostasis is altered in small and non-small cell lung cancer cell lines
por: Bergner, Albrecht, et al.
Publicado: (2009)

Prospective Analysis on Survival Outcomes of Nonsmall Cell Lung Cancer Stages over Ⅲb Treated with HangAm-Dan
por: JEONG, Tae-Young, et al.
Publicado: (2010)

Multispectral imaging and objective assessment of immune-tumor interactions in non-small cell lung cancer
por: Ballesteros-Merino, Carmen, et al.
Publicado: (2015)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
por: Kaira, K, et al.
Publicado: (2008)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential
por: Liu, Xiaoqing, et al.
Publicado: (2020)

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
por: Taugner, Julian, et al.
Publicado: (2020)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer
por: Açikgoz, Yusuf, et al.
Publicado: (2020)

Long‐term outcomes of high‐dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer
por: Ohnishi, Kayoko, et al.
Publicado: (2021)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
por: Escobar, Mauricio, et al.
Publicado: (2011)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2013)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

A Staging Auxiliary Diagnosis Model for Nonsmall Cell Lung Cancer Based on the Intelligent Medical System
por: Wu, Jia, et al.
Publicado: (2021)

Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
por: Guibert, Nicolas, et al.
Publicado: (2020)

An interdisciplinary multimodal integrative healthcare program for depressive and anxiety disorders
por: Wijnen, Jaap, et al.
Publicado: (2023)

Impacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer
por: Lei, Weijie, et al.
Publicado: (2017)

Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Gennen, Kathrin, et al.
Publicado: (2020)

The Interdisciplinary Management of Lung Cancer in the European Community
por: Bertolaccini, Luca, et al.
Publicado: (2022)

Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?
por: Nguyen, Nam P., et al.
Publicado: (2016)

Early Stage Finding of an Immune-Enhanced Genetic Subtype of Nonsmall Cell Lung Cancer Related with T-Cell Depletion
por: yang, Ying, et al.
Publicado: (2022)

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
por: Gomez, Daniel R., et al.
Publicado: (2012)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
por: Miyazaki, Kunihiko, et al.
Publicado: (2018)

Solitary fibular metastasis from nonsmall cell lung carcinoma
por: Akram, Mohammad, et al.
Publicado: (2017)

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer
por: Ye, Liang, et al.
Publicado: (2017)

Interleukin-33 Involvement in Nonsmall Cell Lung Carcinomas: An Update
por: Casciaro, Marco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e664uqh36huj9k83d19ipkqq8h